Cutting back on antipsychotics: new study explores who can stop safely
NCT ID NCT07343193
First seen Jan 21, 2026 · Last updated Jun 17, 2026 · Updated 28 times
Summary
This study examines real-life cases where adults with psychotic disorders successfully reduced or stopped their antipsychotic medication. Researchers aim to understand when and how deprescribing can work safely, balancing the risk of relapse with the burden of side effects. The goal is to provide practical guidance for doctors and patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PSYCHOTIC DISORDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Psychiatrie 1 - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.